0 Комментарии
0 Поделились
52 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
- Войдите, чтобы отмечать, делиться и комментировать!
- Primary Sclerosing Cholangitis Market Is Driven By Increasing Drug ApprovalsThe primary sclerosing cholangitis (PSC) market overview comprises growing prevalence of autoimmune and inflammatory liver diseases globally. Primary sclerosing cholangitis is a chronic condition that causes progressive inflammation and scarring of bile ducts in the liver. Some key symptoms include fatigue, jaundice and itching. Current treatment involves management of symptoms,...0 Комментарии 0 Поделились 748 Просмотры 0 предпросмотр
- Primary Sclerosing Cholangitis Market Estimated to Witness High Growth Owing to Increasing Disease PrevalencePrimary sclerosing cholangitis (PSC) is a chronic progressive liver disease that causes inflammation and scarring of the bile ducts. It is currently one of the leading causes of liver disease and transplantation in the developed world. PSC is a long-term condition with no cure where the bile ducts inside and outside the liver become inflamed and scarred over time, restricting the flow of bile....0 Комментарии 0 Поделились 783 Просмотры 0 предпросмотр
- Primary Sclerosing Cholangitism Market Is Estimated To Witness High Growth Owing To Rising Disease PrevalencePrimary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease characterized by multifocal fibrosis of both intra- and extra-hepatic bile ducts. It is associated with ulcerative colitis in 70–80% of cases. The disease course is variable but often progresses to end-stage liver disease leading to liver transplantation. Currently, there is no approved medical treatment for PSC....0 Комментарии 0 Поделились 768 Просмотры 0 предпросмотр